Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intracardiac Flow Assessment in Cardiac Amyloidosis

NCT05379101 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05379101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05379101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intracardiac Flow Assessment in Cardiac Amyloidosis
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
July 20, 2022
Completion date
May 31, 2026
Enrollment
81 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis cardiac, healthy adults